» Articles » PMID: 32879739

Cervical Cancer Screening Uptake and Associated Factors Among HIV-Positive Women in Ethiopia: A Systematic Review and Meta-Analysis

Overview
Journal Adv Prev Med
Specialty Public Health
Date 2020 Sep 4
PMID 32879739
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Women living with human immunodeficiency virus (HIV) are more likely to develop an increased risk of invasive cervical cancer. Morbidity and mortality due to cervical cancer could be reduced with early detection through cervical screening. Though uptake of cervical screening was investigated in Ethiopia, inconsistent findings were reported. Therefore, this systematic review and meta-analysis was designed to estimate the pooled prevalence of cervical cancer screening uptake among HIV-positive women and its associated factors in Ethiopia.

Methods: A comprehensive search of PubMed/MEDLINE, Scopus, EMBASE, CINAHL, Google Scholar, Science Direct, and Cochrane Library was conducted. The data were extracted using a standardized data extraction format. Statistical analysis was done using the STATA, version 14, software. The heterogeneity of the studies was assessed using the test. Funnel plots and Egger's test were used to check publication bias. A random effects model was computed to estimate the pooled prevalence of cervical cancer screening uptake. Moreover, pooled odds ratios with 95% confidence intervals were used to determine the association of identified determinant factors with cervical cancer screening uptake.

Results: A total of 10358 studies were retrieved, and 7 studies were included in the meta-analysis. The pooled prevalence of cervical cancer screening uptake among HIV-positive women in Ethiopia was 18.17% (95% CI : 11.23, 25.10) with exhibited heterogeneity (  = 96.6%; < 0.001). Educational status of women (AOR = 3.50; 95% CI : 1.85, 6.07), knowledge of women on cervical cancer (AOR = 3.26; 95% CI : 2.50, 4.43), and perceived susceptibility (AOR = 3.26; 95% CI : 2.26, 4.26) were significantly associated with cervical cancer screening uptake among HIV-positive women.

Conclusion: The uptake of cervical cancer screening among HIV-positive women in Ethiopia was low. The findings of this study suggest the need to improve the existing national strategies of cervical cancer screening so as to strengthen reproductive health education and promotion, in addition to providing screening services. Furthermore, cervical screening service should be integrated to the routine care and treatment, so that HIV-positive women can get counseling services in every clinical contact.

Citing Articles

Integrated cervical cancer screening uptake and associated factors among women attending primary care services at public health centres in Addis Ababa, Ethiopia: a multicentre cross-sectional study.

Kassa R, Gelaye K, Omigbodun A BMJ Public Health. 2025; 2(2):e001511.

PMID: 40018583 PMC: 11816944. DOI: 10.1136/bmjph-2024-001511.


Cervical Cancer Screening Utilization and Barriers to Uptake in Ethiopia: .

Mohammed E, Taye G, Assefa M, Aman H, Addissie A, Jemal A Cancer Control. 2024; 31:10732748241310575.

PMID: 39705168 PMC: 11662379. DOI: 10.1177/10732748241310575.


Awareness, attendance, and attitudes toward cervical cancer screening among HIV-positive Chinese women in Yunnan province: a cross-sectional study.

Hu J, Duan R, Zhang H, Zhao X, Wu A, Li L BMC Womens Health. 2024; 24(1):636.

PMID: 39633302 PMC: 11616238. DOI: 10.1186/s12905-024-03478-1.


Service-Delivery Models to Increase the Uptake of Non-Communicable Disease Screening in South-Central Ethiopia: A Difference-In-Differences Analysis.

Ketema B, Addissie A, Negash S, Bekele M, Wienke A, Kaba M Diseases. 2024; 12(11).

PMID: 39589953 PMC: 11593248. DOI: 10.3390/diseases12110278.


Early adoption of innovation in HPV prevention strategies: closing the gap in cervical cancer.

Mahajan I, Kadam A, McCann L, Ghose A, Wakeham K, Dhillon N Ecancermedicalscience. 2024; 18:1762.

PMID: 39430092 PMC: 11489098. DOI: 10.3332/ecancer.2024.1762.


References
1.
Tabrizi S, Brotherton J, Kaldor J, Skinner S, Cummins E, Liu B . Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis. 2012; 206(11):1645-51. DOI: 10.1093/infdis/jis590. View

2.
McDonald A, Tergas A, Kuhn L, Denny L, Wright Jr T . Distribution of Human Papillomavirus Genotypes among HIV-Positive and HIV-Negative Women in Cape Town, South Africa. Front Oncol. 2014; 4:48. PMC: 3953716. DOI: 10.3389/fonc.2014.00048. View

3.
Bucciardini R, Fragola V, Abegaz T, Lucattini S, Halifom A, Tadesse E . Retention in Care of Adult HIV Patients Initiating Antiretroviral Therapy in Tigray, Ethiopia: A Prospective Observational Cohort Study. PLoS One. 2015; 10(9):e0136117. PMC: 4560381. DOI: 10.1371/journal.pone.0136117. View

4.
Clifford G, Franceschi S, Keiser O, Schoni-Affolter F, Lise M, Dehler S . Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study. Int J Cancer. 2015; 138(7):1732-40. DOI: 10.1002/ijc.29913. View

5.
Getahun F, Addissie A, Negash S, Gebremichael G . Assessment of cervical cancer services and cervical cancer related knowledge of health service providers in public health facilities in Addis Ababa, Ethiopia. BMC Res Notes. 2019; 12(1):675. PMC: 6805432. DOI: 10.1186/s13104-019-4701-6. View